The use of FTIR microscopy for the evaluation of anti-bacterial agents activity

Journal of Photochemistry and Photobiology B: Biology

Volumn 96, Issue 1, 2009, Pages 17-23

  Huleihel, Mahmoud ^a   Pavlov, Valentina ^a   Erukhimovitch, Vitaly ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Anti bacterial activity; Bacteria; CAPE; Drug efficiency; FTIR microspectroscopy; Propolis

Indexed keywords

AMPICILLIN; CAFFEIC ACID PHENETHYL ESTER;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INFRARED SPECTROSCOPY; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL;

AMPICILLIN; ANTI-BACTERIAL AGENTS; CAFFEIC ACIDS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; PHENYLETHYL ALCOHOL; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

APIS MELLIFERA; BACTERIA (MICROORGANISMS);

EID: 67349086086     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2009.03.009     Document Type: Article

References (27)

1. Maquelin K., Kirschner C., Choo-Smith L.P., et al. Prospective study of the performance of vibrational spectroscopies for rapid identification of bacterial and fungal pathogens recovered from blood cultures. J. Clin. Microbiol. 41 (2003) 324-429
2. Essendoubi M., Toubas D., Bouzaggou M., Pinon J.M., and Manfait M. Rapid identification of Candida species by FT-IR microspectroscopy. Biochim. Biophys. Acta 1724 (2005) 239-247
3. Miller J.M., and O'Hara C.M. In: Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., and Yolken R.H. (Eds). Manual of Clinical Microbiology (1999), ASM press, Washington, DC 193-201
4. Naumann D., Helm D., and Labischinski H. Microbiological characterizations by FT-IR spectroscopy. Nature 351 (1991) 81-82
5. Erukhimovitch V., Pavlov V., Talyshinsky M., Souprun Y., and Huleihel M. FTIR microscopy as a method for identification of bacterial and fungal infections. J. Pharmaceut. Biomed. Anal. 37 (2005) 1105-1108
6. Wang H.P., Wang H.C., and Huang Y.J. Microscopic FTIR studies of lung cancer cells in pleural fluid. Sci. Total. Environ. 204 (1997) 283-287
7. Gao T., Feng J., and Ci Y. Human breast carcinomal tissues display distinctive FTIR spectra: implication for the histological characterization of carcinomas. Anal. Cell. Pathol. 18 (1999) 87-93
8. Rigas B., LaGuardia K., Qiao L., Bhandare B.S., Caputo T., and Cohenford M.A. Infrared spectroscopic study of cervical smears in patients with HIV: implications for cervical carcinogenesis. J. Lab. Clin. Med. 35 (2000) 26-31
9. Erukhimovitch V., Talyshinsky M., Souprun Y., and Huleihel M. Spectroscopic characterization of human and mouse primary cells, cell lines and malignant cells. Photochem. Photobiol. 76 (2002) 446-451
10. Huleihel M., Talyshinsky M., Souprun Y., and Erukhimovitch V. Spectroscopic evaluation of cells infected with herpes viruses and treated with red microalgal polysaccharides. Appl. Spectrosc. 57 (2003) 390-395
11. Erukhimovitch V., Talyshinsky M., Souprun Y., and Huleihel M. The use of FTIR microscopy for the evaluation of drugs efficiency. J. Biomed. Opt. 11 (2006) (064009-1-6)
12. Russo A., Troncoso N., Sanchez F., Garbarino J.A., and Vanella A. Propolis protects human spermatozoa from DNA damage caused by benzo[a]pyrene and exogenous reactive oxygen species. Life Sci. 78 (2006) 1401-1406
13. Song Y.S., Jin C., Jung K.J., and Park E.H. Estrogenic effects of ethanol and ether extracts of propolis. J. Ethnopharmacol. 82 (2002) 89-95
14. Russo A., Longo R., and Vanella A. Antioxidant activity of propolis: role of caffeic acid phenethyl ester and galangin. Fitoterapia 73 (2002) S21-S29
15. Onlen Y., Tamer C., Oksuz H., Duran N., Altug A.E., and Yakan S. Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits. Microbiol. Res. 162 (2007) 62-68
16. Broudiscou L.P., Geissler H., and Broudiscou A. Estimation of the growth rate of mixed ruminal bacteria from short-term DNA radiolabeling. Anaerobe 4 (1998) 145-152
17. Dukor R.K. In: Chalmers J.M., and Griffiths P.R. (Eds). Handbook of Vibrational Spectroscopy, Vibrational Spectroscopy in the Detection of Cancer (2001), John Wiley and Sons, New York 3335-3361
18. Yang D., Castro D., El-Sayed I., El-Sayed M., Saxton R., and Zhang N.Y. A Fourier-transform infrared spectroscopic comparison of cultured human fibroblast and fibrosarcoma cells: a new method for detection of malignancies. J. Clin. Laser Med. Surg. 13 (1995) 55-59
19. Dukor R.R., Liebman M.N., and Johnson B.L. A new, non-destructive method for analysis of clinical samples with FT-IR microspectroscopy, breast cancer tissue as an example. Cell Mol. Biol. 44 (1998) 211-217
20. Brandenburg K., and Seydel U. In: Chalmers J.M., and Griffiths P.R. (Eds). Handbook of Vibrational Spectroscopy, Vibrational Spectroscopy of Carbohydrates and Glycoconjugates (2001), John Wiley and Sons, New York 3481-3507
21. Taillandier A.E., and Liguier J. In: Chalmers J.M., and Griffiths P.R. (Eds). Handbook of Vibrational Spectroscopy, Vibrational Spectroscopy of Nucleic Acids (2001), John Wiley and Sons, New York 3465-3480
22. Peng X., Xu C., Ren H., Lin X., Wu L., and Wang S. Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Pseudomonas aeruginosa responding to ampicilin, kanamycin, and tetracycline resistance. J. Proteome Res. 4 (2005) 2257-2265
23. Yang C., Wu J., Zhang R., Zhang P., Eckard J., Yusuf R., Huang X., Rossman T.G., and Frenkel K. Caffeic acid phenethyl ester (CAPE) prevents transformation of human cells by arsenite (As) and suppresses growth of As-transformed cells. Toxicology 213 (2005) 81-96
24. Song Y.S., Park E.H., Hur G.M., Ryu Y.S., Lee Y.S., Lee J.Y., Kim Y.M., and Jin C. Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Lett. 175 (2002) 53-61
25. Marquez N., Sancho R., Macho A., Calzado M., Fiebich B., and Munoz E. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors. J. Pharmacol. Exp. Ther. 308 (2004) 993-1001
26. Pahl H.L. Activators and target genes of Rel/NF-kB transcription factors. Oncogene 18 (1999) 6853-6866
27. Perkins N.D., and Gilmore T.D. Good cop, bad cop: the different faces of NF-Kb. Cell Death Differ. 13 (2006) 759-772